Literature DB >> 27784812

The protective role of vitamin D on the heart and the kidney.

Walter Manucha1, Luis I Juncos2.   

Abstract

For a long time, vitamin D was regarded as an essential component for the maintenance of appropriate calcium metabolism. Indeed, the calcium-related functions were broadly studied and validated in numerous clinical and epidemiologic studies. All of these vitamin D effects are mediated by a specific receptor. Remarkably, recent investigations show that the vitamin D receptor (VDR) also affects autoimmunity and by these means, the course of neoplasias and tissue inflammation. Moreover, the VDR regulates genes that affect cellular activity including cell differentiation and apoptosis and, by these means, angiogenesis. Actually, vitamin D deficiency has been associated with structural and functional cardiovascular changes that can be reversed by receptor stimulation. In this regard, some of the injurious effects of vitamin D deficiency such as myocardial hypertrophy and high blood pressure seem linked to increased renin-angiotensin activity. Interestingly, chronic renal disease, a condition often associated with greater cardiovascular risk, high blood pressure, myocardial hypertrophy and inappropriate stimulation of the renin angiotensin system, is also tied to inadequate vitamin D activity. In fact, studies in several animal models such as the rat ureteral obstruction model, the 5/6 nephrectomy model and others, clearly show that VDR stimulation prevents both structural and functional changes in the heart and the kidney. Clinical trials are needed to validate the vitamin D potential benefits in chronic kidney disease and its associated cardiovascular risk.
© The Author(s), 2016.

Entities:  

Keywords:  cardiovascular risk; chronic kidney disease; vitamin D receptor

Year:  2016        PMID: 27784812      PMCID: PMC5933557          DOI: 10.1177/1753944716675820

Source DB:  PubMed          Journal:  Ther Adv Cardiovasc Dis        ISSN: 1753-9447


  47 in total

1.  Effects of paricalcitol and enalapril on atherosclerotic injury in mouse aortas.

Authors:  Kazim Husain; Edu Suarez; Angel Isidro; Leon Ferder
Journal:  Am J Nephrol       Date:  2010-08-17       Impact factor: 3.754

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  Ultraviolet B and blood pressure.

Authors:  R Krause; M Bühring; W Hopfenmüller; M F Holick; A M Sharma
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

4.  Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats.

Authors:  Juan Kong; Gene H Kim; Minjie Wei; Tao Sun; George Li; Shu Q Liu; Xinmin Li; Ishir Bhan; Qun Zhao; Ravi Thadhani; Yan Chun Li
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

5.  Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate.

Authors:  Rajiv Agarwal; Jennifer E Hynson; Tyler J W Hecht; Robert P Light; Arjun D Sinha
Journal:  Kidney Int       Date:  2011-06-29       Impact factor: 10.612

Review 6.  Inflammation, oxidative stress and renin angiotensin system in atherosclerosis.

Authors:  Kazim Husain; Wilfredo Hernandez; Rais A Ansari; Leon Ferder
Journal:  World J Biol Chem       Date:  2015-08-26

7.  Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats.

Authors:  Kazim Husain; Leon Ferder; Masahide Mizobuchi; Jane Finch; Eduardo Slatopolsky
Journal:  Am J Nephrol       Date:  2008-11-26       Impact factor: 3.754

8.  Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice.

Authors:  Juan Kong; Yan Chun Li
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-03-13       Impact factor: 3.619

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

10.  The Association of Vitamin D Status with Dyslipidaemia and Biomarkers of Endothelial Cell Activation in Older Australians.

Authors:  Ali M Alyami; Virginie Lam; Mario J Soares; Yun Zhao; Jillian L Sherriff; John C Mamo; Anthony P James; Fiona Coombes
Journal:  Nutrients       Date:  2016-07-28       Impact factor: 5.717

View more
  4 in total

Review 1.  Nuclear receptors in the kidney during health and disease.

Authors:  Andrew E Libby; Bryce Jones; Isabel Lopez-Santiago; Emma Rowland; Moshe Levi
Journal:  Mol Aspects Med       Date:  2020-11-30

2.  Determinants of Dietary Vitamin D Intake in Population-Based Cohort Sample of Polish Female Adolescents.

Authors:  Katarzyna Lachowicz; Małgorzata Stachoń
Journal:  Int J Environ Res Public Health       Date:  2022-09-26       Impact factor: 4.614

3.  The association between serum vitamin D levels and renal tubular dysfunction in a general population exposed to cadmium in China.

Authors:  Xiao Chen; Yan Dai; Zhongqiu Wang; Guoying Zhu; Xiaoqiang Ding; Taiyi Jin
Journal:  PLoS One       Date:  2018-04-10       Impact factor: 3.240

Review 4.  The Emerging Role of Vitamin D and Vitamin D Receptor in Diabetic Nephropathy.

Authors:  Min Lei; Zhangsuo Liu; Jia Guo
Journal:  Biomed Res Int       Date:  2020-07-11       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.